EUVIMEDEUVIMED entdecken
Open Access

Cathepsin-Targeting SARS-CoV-2 Inhibitors: Design, Synthesis, and Biological Activity

Philipp Flury, Julian Breidenbach, Nadine Krüger, Rabea Voget, Laura Schäkel, Yaoyao Si, Vesa Krasniqi, Sara Calistri, Matthias Olfert, Katharina Sylvester, Cheila Rocha, Raphael Ditzinger und 9 weitere

ACS Pharmacology & Translational Science · 09.02.2024 · 7 (2) · 493-514

DOI: 10.1021/acsptsci.3c00313 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Pharmacology & Translational Science, online erschienen am 19.01.2024. Verfasst von Philipp Flury und 20 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmacy, Pharmaceutical/Medicinal Chemistry and Tübingen Center for Academic Drug Discovery, Eberhard Karls University Tübingen, Auf de…. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Institute of Pharmacy, Pharmaceutical/Medicinal Chemistry and Tübingen Center for Academic Drug Discovery, Eberhard Karls University Tübingen, Auf der Morgenstelle 8, Tübingen 72076, Germany.
  • PharmaCenter Bonn, Pharmaceutical Institute, Pharmaceutical & Medicinal Chemistry, University of Bonn, An der Immenburg 4, Bonn 53121, Germany.
  • Infection Biology Unit, German Primate Center, Leibniz Institute for Primate Research Göttingen, Kellnerweg 4, Göttingen 37077, Germany.
  • Faculty of Biology and Psychology, University Göttingen, Göttingen 37073, Germany.
  • Faculty of Health Sciences, School of Pharmacy, University of Eastern Finland, Kuopio 70211, Finland.
  • Excellence Cluster "Controlling Microbes to Fight Infections" (CMFI), Tübingen 72076, Germany.

ORCID-Profile: Antti Poso, Stefan A Laufer, Christa E Müller, Michael Gütschow, Thanigaimalai Pillaiyar

Zitieren

APA

Flury, P., Breidenbach, J., Krüger, N., Voget, R., Schäkel, L., Si, Y., Krasniqi, V., Calistri, S., Olfert, M., Sylvester, K., Rocha, C., Ditzinger, R., Rasch, A., Pöhlmann, S., Kronenberger, T., Poso, A., Rox, K., Laufer, S. A., Müller, C. E., …, & Pillaiyar, T. (2024). Cathepsin-Targeting SARS-CoV-2 Inhibitors: Design, Synthesis, and Biological Activity. ACS Pharmacology & Translational Science, 7(2), 493-514. https://doi.org/10.1021/acsptsci.3c00313

Vancouver

Flury P, Breidenbach J, Krüger N, Voget R, Schäkel L, Si Y, et al. Cathepsin-Targeting SARS-CoV-2 Inhibitors: Design, Synthesis, and Biological Activity. ACS Pharmacology & Translational Science. 2024;7(2):493-514. doi:10.1021/acsptsci.3c00313

BibTeX
@article{Flury2024,
  author = {Flury, Philipp and Breidenbach, Julian and Krüger, Nadine and Voget, Rabea and Schäkel, Laura and Si, Yaoyao and Krasniqi, Vesa and Calistri, Sara and Olfert, Matthias and Sylvester, Katharina and Rocha, Cheila and Ditzinger, Raphael and Rasch, Alexander and Pöhlmann, Stefan and Kronenberger, Thales and Poso, Antti and Rox, Katharina and Laufer, Stefan A and Müller, Christa E and Gütschow, Michael and Pillaiyar, Thanigaimalai},
  title = {Cathepsin-Targeting SARS-CoV-2 Inhibitors: Design, Synthesis, and Biological Activity},
  journal = {ACS Pharmacology & Translational Science},
  year = {2024},
  volume = {7},
  number = {2},
  pages = {493--514},
  doi = {10.1021/acsptsci.3c00313}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche